Skip to Main Content

Paper Details

Dissecting the IL-6 pathway in cardiometabolic disease: A Mendelian randomization study on both IL6 and IL6R.
British Journal of Clinical Pharmacology
18
2022
Author NameAffiliation
Pradeep NatarajanCardiovascular Research Center, Massachusetts General Hospital, Harvard Medical School
Pradeep NatarajanBroad Institute of Harvard and MIT
Paul M RidkerCenter for Cardiovascular Disease Prevention, Brigham and Women's Hospital, Harvard Medical School
Gerard K HovinghAmsterdam University Medical Centers, University of Amsterdam
  • 1 - 4

Datasets